PeptideNerds

The Female Wellness Stack

Designed specifically for women's health needs. BPC-157 supports gut health and recovery, GHK-Cu targets skin elasticity and collagen production, and PT-141 addresses sexual health and desire through melanocortin receptor activation.

Difficulty

intermediate

Est. Cost

$150-350

Duration

2-3 months (BPC-157 + GHK-Cu), PT-141 as needed

Peptides

3 compounds

Protocol

Peptide Dose Frequency Timing Role
BPC-157 250mcg Once daily Morning, oral or SubQ Gut health support, overall tissue repair, mood support
GHK-Cu Topical serum 2x daily or 1mg SubQ once daily Daily Morning and evening (topical) or morning (SubQ) Collagen and elastin synthesis, skin tightening, gene expression reset
PT-141 0.5-1mg (lower dose for women) As needed, max 2x per week 1-2 hours before desired effect Melanocortin-4 receptor agonist for sexual desire and arousal

Notes

This stack addresses three common wellness concerns for women over 40. BPC-157 at low daily dose supports gut health (important during hormonal changes) and has mood-supporting properties. GHK-Cu drives real skin improvements through collagen synthesis and gene expression changes (not just surface-level). PT-141 (bremelanotide, FDA-approved as Vyleesi) works through the central nervous system, not hormones, making it suitable alongside HRT. Start PT-141 at 0.5mg (women need lower doses than men). Nausea is the most common side effect of PT-141; it typically diminishes after first use. Do not combine PT-141 with naltrexone.

Related goals

Related stacks

Free Peptide Weight Loss Guide

Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.

Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated March 2026

Medical Disclaimer: Peptide stacks are not FDA-approved protocols. This information is for educational purposes only. Consult a qualified healthcare provider before combining any peptides.